Increased incidence of childhood lymphoma in children with a history of small for gestational age at birth

Arch Gynecol Obstet. 2022 Nov;306(5):1485-1494. doi: 10.1007/s00404-022-06410-w. Epub 2022 Feb 8.

Abstract

Objective: The aim of this study was to evaluate whether children that were born small for gestational age (SGA) have an increased risk for childhood neoplasm.

Study design: A population-based cohort analysis comparing the risk for long-term childhood neoplasms (benign and malignant) in children that were born SGA vs. those that were appropriate for gestational age (AGA), between the years1991-2014. Childhood neoplasms were predefined based on ICD-9 codes, as recorded in the hospital medical files. Kaplan-Meier survival curves were constructed to compare cumulative oncological morbidity in both groups over time. Cox proportional hazards model was used to control for confounders.

Results: During the study period 231,973 infants met the inclusion criteria; out of those 10,998 were born with a diagnosis of SGA. Children that were SGA at birth had higher incidence of lymphoma (OR 2.50, 95% CI 1.06-5.82; p value = 0.036). In addition, cumulative incidence over time of total childhood lymphoma was significantly higher in SGA children (Log Rank = 0.030). In a Cox regression model controlling for other perinatal confounders; SGA at birth remained independently associated with an increased risk for childhood lymphoma (adjusted HR 2.41, 95% CI 1.03-5.56, p value = 0.043).

Conclusion: Being delivered SGA is associated with an increased long-term risk for childhood malignancy and specifically lymphoma.

Keywords: Childhood malignancy; Lymphoma; Small for gestational age.

MeSH terms

  • Child
  • Female
  • Gestational Age
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Lymphoma* / epidemiology
  • Neoplasms* / epidemiology
  • Pregnancy
  • Retrospective Studies
  • Risk Factors